Reclassifying pediatric NAFLD using the steatotic liver disease framework: a multicenter retrospective study from the NASH CRN. Read more about Reclassifying pediatric NAFLD using the steatotic liver disease framework: a multicenter retrospective study from the NASH CRN.
Immune-mediated adverse events and overall survival with tremelimumab plus durvalumab and durvalumab monotherapy in unresectable hepatocellular carcinoma: HIMALAYA phase 3 randomized clinical trial. Read more about Immune-mediated adverse events and overall survival with tremelimumab plus durvalumab and durvalumab monotherapy in unresectable hepatocellular carcinoma: HIMALAYA phase 3 randomized clinical trial.
A prospective multicenter validation of RETREAT for posttransplantation HCC recurrence prediction. Read more about A prospective multicenter validation of RETREAT for posttransplantation HCC recurrence prediction.
Downstaging of hepatocellular carcinoma before liver transplantation: Results from a national multicenter prospective cohort study. Read more about Downstaging of hepatocellular carcinoma before liver transplantation: Results from a national multicenter prospective cohort study.
Longitudinal response to standard of care in pediatric metabolic dysfunction-associated steatotic liver disease: Rates of improvement and worsening, and factors associated with outcomes. Read more about Longitudinal response to standard of care in pediatric metabolic dysfunction-associated steatotic liver disease: Rates of improvement and worsening, and factors associated with outcomes.
Evaluating the positive predictive value of code-based identification of cirrhosis and its complications utilizing GPT-4. Read more about Evaluating the positive predictive value of code-based identification of cirrhosis and its complications utilizing GPT-4.
Liver transplantation provides survival benefit at all levels of frailty: From the Multicenter Functional Assessment in Liver Transplantation Study. Read more about Liver transplantation provides survival benefit at all levels of frailty: From the Multicenter Functional Assessment in Liver Transplantation Study.
Reply: The exact predictive value of HBcrAg and HBV RNA in serological status and disease activity in CHB. Read more about Reply: The exact predictive value of HBcrAg and HBV RNA in serological status and disease activity in CHB.
Diagnostic accuracy of serum matrix metalloproteinase-7 as a biomarker of biliary atresia in a large North American cohort. Read more about Diagnostic accuracy of serum matrix metalloproteinase-7 as a biomarker of biliary atresia in a large North American cohort.
